Justin Eyquem

Statistics

Publications

Citations

7.6K

H-Index

Active since

2013

Affiliations

University of California, San Francisco(Current)

Gladstone Institutes

Parker Institute for Cancer Immunotherapy

UCSF Helen Diller Family Comprehensive Cancer Center

Memorial Sloan Kettering Cancer Center

Justin Eyquem is an author at University of California, San Francisco specializing in life sciences, immunology, and chimeric antigen receptor t-cell therapy.

ORCID

Publications per year

2013–2026

Publications

Targeting a CAR to the TRAC locus with CRISPR/Cas9 enhances tumour rejection

Justin Eyquem, Jorge Mansilla‐Soto, Theodoros Giavridis et al. · Nature · 2017 · 1.8K citations · Full text

Life Sciences, Genetics, Molecular Biology +12

CAR T cell–induced cytokine release syndrome is mediated by macrophages and abated by IL-1 blockade

Theodoros Giavridis, Sjoukje J. C. van der Stegen, Justin Eyquem et al. · Nature Medicine · 2018 · 1.3K citations · Full text

Life Sciences, Cell Biology, Immunology +16

CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape

Mohamad Hamieh, Anton Dobrin, Annalisa Cabriolu et al. · Nature · 2019 · 656 citations · Full text

Life Sciences, Cancer Biology, Immunology +14

Multiplex Genome-Edited T-cell Manufacturing Platform for “Off-the-Shelf” Adoptive T-cell Immunotherapies

Laurent Poirot, Brian Philip, Cécile Schiffer-Mannioui et al. · Cancer Research · 2015 · 596 citations

Life Sciences, Biotechnology, Immunology +17

Calibration of CAR activation potential directs alternative T cell fates and therapeutic potency

Judith Feucht, Jie Sun, Justin Eyquem et al. · Nature Medicine · 2018 · 543 citations · Full text

Life Sciences, Cell Biology, Immunology +10

1–5 of 36